Medchemexpress LLC N-methyl-3-(pyrido[2,3-d]pyrimidin-7-yl)benzamide derivative | 1567915-38-1 | 100.0% | 474.55 | C26H30N6O3 | 5MG

Supplier:  Medchemexpress LLC HY1260775MG

MTI-31 is a potent, selective inhibitor of mTORC1 and mTORC2 used in preclinical research to probe PI3K/Akt/mTOR signaling and antitumor activity. It is supplied as a solid research compound intended for laboratory in vitro and in vivo studies; consult the manufacturer's datasheet for handling and safety details.

• Selective mTORC1/mTORC2 inhibitor with reported Kd 0.20 nM.
• Used to study PI3K/Akt/mTOR pathway and antitumor responses.
• Molecular formula C26H30N6O3 and molecular weight 474.55.
• Purity 99.98% (manufacturer reported).
• Solid, white to yellow; supplied as a 5 mg quantity.
• Storage: powder -20°C (3 years) or 4°C (2 years); in solvent -80°C (6 months) or -20°C (1 month).

Catalog No. 50-002-38138